DTSyn: a dual-transformer-based neural network to predict synergistic drug combinations
J Hu, J Gao, X Fang, Z Liu, F Wang… - Briefings in …, 2022 - academic.oup.com
Drug combination therapies are superior to monotherapy for cancer treatment in many ways.
Identifying novel drug combinations by screening is challenging for the wet-lab experiments …
Identifying novel drug combinations by screening is challenging for the wet-lab experiments …
DTSyn: a dual-transformer-based neural network to predict synergistic drug combinations
J Hu, J Gao, X Fang, Z Liu, F Wang, W Huang, H wu… - bioRxiv, 2022 - biorxiv.org
Drug combination therapies are superior to monotherapy for cancer treatment in many ways
when addressing tumor heterogeneity issue. For wet-lab experiment, screening out novel …
when addressing tumor heterogeneity issue. For wet-lab experiment, screening out novel …
DTSyn: a dual-transformer-based neural network to predict synergistic drug combinations
J Hu, J Gao, X Fang, Z Liu, F Wang… - Briefings in …, 2022 - academic.oup.com
Drug combination therapies are superior to monotherapy for cancer treatment in many ways.
Identifying novel drug combinations by screening is challenging for the wet-lab experiments …
Identifying novel drug combinations by screening is challenging for the wet-lab experiments …
[PDF][PDF] DTSyn: a dual-transformer-based neural network to predict synergistic drug combinations
J Hu, J Gao, X Fang, Z Liu - scholar.archive.org
Drug combination therapies are superior to monotherapy for cancer treatment in many ways
when addressing tumor heterogeneity issue. For wet-lab experiment, screening out novel …
when addressing tumor heterogeneity issue. For wet-lab experiment, screening out novel …
DTSyn: a dual-transformer-based neural network to predict synergistic drug combinations.
J Hu, J Gao, X Fang, Z Liu, F Wang… - Briefings in …, 2022 - search.ebscohost.com
Drug combination therapies are superior to monotherapy for cancer treatment in many ways.
Identifying novel drug combinations by screening is challenging for the wet-lab experiments …
Identifying novel drug combinations by screening is challenging for the wet-lab experiments …
DTSyn: a dual-transformer-based neural network to predict synergistic drug combinations.
J Hu, J Gao, X Fang, Z Liu, F Wang… - Briefings in …, 2022 - europepmc.org
Drug combination therapies are superior to monotherapy for cancer treatment in many ways.
Identifying novel drug combinations by screening is challenging for the wet-lab experiments …
Identifying novel drug combinations by screening is challenging for the wet-lab experiments …
DTSyn: a dual-transformer-based neural network to predict synergistic drug combinations
J Hu, J Gao, X Fang, Z Liu, F Wang… - Briefings in …, 2022 - pubmed.ncbi.nlm.nih.gov
Drug combination therapies are superior to monotherapy for cancer treatment in many ways.
Identifying novel drug combinations by screening is challenging for the wet-lab experiments …
Identifying novel drug combinations by screening is challenging for the wet-lab experiments …
DTSyn: a dual-transformer-based neural network to predict synergistic drug combinations
J Hu, J Gao, X Fang, Z Liu, F Wang, W Huang, G Zhao - 2022 - europepmc.org
Drug combination therapies are superior to monotherapy for cancer treatment in many ways
when addressing tumor heterogeneity issue. For wet-lab experiment, screening out novel …
when addressing tumor heterogeneity issue. For wet-lab experiment, screening out novel …